戻る Agenda
How Do You Oversee and Manage New Centralized/Remote/Site Monitoring Models? What Should you Measure to Gain Insights?
Session Chair(s)
Linda B Sullivan, MBA
Senior Fellow
Tufts Center For the Study of Drug Development, United States
An industry consortium has been developing a set of metrics to measure the process of centralized and site monitoring. The forum will provide insights into the approach, the progress, and plans to obtain further industry feedback.
Learning Objective : Describe methodologies for developing metrics to monitor the processes related to centralized, remote and site monitoring; Discuss some of the challenges of developing metrics to monitor risk-based processes.
Speaker(s)
Panelist
Charles Lawrence Liss, MS
CSL Behring, United States
Associate Director, Global Biostatistics
Panelist
Barbara Novak
Kyowa Kirin, US, United States
Systems and Process Management Lead, Clinical Operations- NA/EU
Panelist
Joe Kunakorn, MS
Janssen Research & Development, LLC, United States
Associate Director, Oncology Risk Management
Panelist
Jacqueline Gough, MS
Astellas, United States
Director, Central Monitoring and Data Surveillance